Provided by Tiger Trade Technology Pte. Ltd.

Ginkgo Bioworks Holdings Inc.

7.40
+0.44006.32%
Post-market: 7.470.0701+0.95%19:48 EDT
Volume:1.44M
Turnover:10.41M
Market Cap:498.32M
PE:-1.49
High:7.42
Open:7.09
Low:6.82
Close:6.96
52wk High:17.58
52wk Low:5.37
Shares:67.34M
Float Shares:49.87M
Volume Ratio:1.01
T/O Rate:2.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9625
EPS(LYR):-5.6397
ROE:-59.94%
ROA:-16.72%
PB:1.19
PE(LYR):-1.31

Loading ...

Graceful Home Presents DNA Test Results and Marriage Certificate to Address Recent Controversies

Deep News
·
May 19

Jellyfish Reveals DNA Test Results, Marriage and Birth Certificates to Address Speculation

Deep News
·
May 19

DNA X, Inc. Delays Quarterly Filing After Asset Sale

TIPRANKS
·
May 16

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

prnewswire
·
May 14

Lotus Unveils Focus 2030 – Reinforcing Brand DNA with an All-New Hybrid-V8 Supercar

GlobeNewswire
·
May 12

Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)

TIPRANKS
·
May 11

Is Inovio (INO) Turning Fresh DNA Medicine Data Into a More Coherent Investment Story?

Simply Wall St.
·
May 10

Ginkgo Bioworks Q1 revenue falls 49% on restructuring

Reuters
·
May 08

Ginkgo Bioworks reaffirms 2026 expected total cash burn of ($150M)-($125M)

TIPRANKS
·
May 08

Ginkgo Q1 FY26 net loss narrows 8.36% to $(76) million; revenue drops 49% to $19 million

Reuters
·
May 08

Ginkgo Bioworks Holdings Q1 EPS $(1.39) Misses $(1.34) Estimate, Sales $19.474M Miss $41.520M Estimate

Benzinga Earnings
·
May 08

BRIEF-Ginkgo Bioworks Q1 Net Income USD -82.587 Million

Reuters
·
May 08

Ginkgo Bioworks Holdings Inc - Reaffirms 2026 Total Cash Burn Guidance of $(150)-$(125) Mln

THOMSON REUTERS
·
May 08

Press Release: Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Dow Jones
·
May 08

Ginkgo Bioworks Holdings Inc expected to post a loss of $1.08 a share - Earnings Preview

Reuters
·
May 06

Ginkgo Bioworks to host first-quarter results presentation and Q&A session

Reuters
·
Apr 30

Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer

GlobeNewswire
·
Apr 29

Eli Lilly Emerges as Top Contender in Pharma's AI Arms Race with $2.25 Billion Profluent Partnership for DNA Editing Tech

Stock News
·
Apr 28

Cellectis Presents Epigenetic Editing Platform to Turn Genes Off Without Altering DNA at the ASGCT Annual Meeting

GlobeNewswire
·
Apr 28

How to Avoid Fistfights and DNA Leaks at a World Leaders Summit -- WSJ

Dow Jones
·
Apr 27